Calls Purchased on Keryx Biopharmaceuticals (KERX)

Shares of Keryx Biopharmaceuticals KERX are higher on the session by 0.87%, currently trading at $4.64. The stock has been moving largely higher over the past three months and is currently trading above the 200-day moving average. Options traders are buying calls on the name today. A short while ago the June 2011 $5.00 call was purchased 3,000 times, on the offer, on open interest of 4,944 contracts. Overall call volume is now running at 4.28x the daily average with 100% of all calls traded being purchases on the offer. Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.